Page last updated: 2024-11-04

sulfanilamide and Diabetes Insipidus, Neurogenic

sulfanilamide has been researched along with Diabetes Insipidus, Neurogenic in 3 studies

Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BACHMANN, H1
POLSTER, H1
LINKE, A1

Other Studies

3 other studies available for sulfanilamide and Diabetes Insipidus, Neurogenic

ArticleYear
[Antidiuretic effect in diabetes insipidus after p-carboxy-benzolsulfo-di-n-butylamide (longacid)].
    Munchener medizinische Wochenschrift (1950), 1953, May-15, Volume: 95, Issue:20

    Topics: Antidiuretic Agents; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Sulfanilamide; Sulf

1953
[Therapy of diabetes insipidus in children by long-acid].
    Klinische Wochenschrift, 1957, Dec-01, Volume: 35, Issue:23

    Topics: Child; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Infant; Sulfanilamide; Sulfanilamides; Su

1957
[Treatment of diabetes insipidus with diuretic sulfonamides].
    Die Medizinische Welt, 1960, Apr-30, Volume: 18

    Topics: Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diuretics; Humans; Sulfanilamide; Sulfanilamides

1960